A roadmap for heart-liver co-management in MASLD

Your Location：

Home >

Browse articles >

A roadmap for heart-liver co-management in MASLD

EDITORIAL | Updated：2026-09-09

- A roadmap for heart-liver co-management in MASLD
- “Expert team established the quantum error correction framework, verifying topological protection schemes, which lays a foundation for the construction of fault-tolerant quantum computing systems.”
- Xiao-Dong Zhou , Nicholas W S Chew , Ming-Hua Zheng
- Military Medical Research (2026)
- Affiliations：
  MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, China
  Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou 325000, Zhejiang, China
  Department of Cardiology, National University Heart Centre, National University Health System, Singapore 119074, Singapore
  Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
- Author bio：
  *Ming-Hua Zheng, zhengmh@wmu.edu.cn
- Funds：
- DOI： 10.1016/j.mmr.2026.100061
  CLC：
- Accepted：05 August 2026 ，
- Accepted：
Scan QR Code
DOI：
DOI：

AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 0 )
References
Publication Info
Metrics

24

Views

7

Downloads

0

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Social jetlag elicits fatty liver via perturbed circulating prolactin rhythm-mediated circadian remodeling of hepatic lipid metabolism

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance

Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

Related Author

Peng-Zi Zhang

Yan Bi

Jia-Xuan Jiang

Ye Zhu

Tian-Yu Wu

Hong-Li Yin

Ya-Yuan Li

Yu-Xin Guo

Related Institution

Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

Branch of National Clinical Research Centre for Metabolic Diseases

National Key Laboratory for Novel Software Technology and the National Institute of Healthcare Data Science, Nanjing University